TP53 mutations in human cancers: origins, consequences, and clinical use.

Cited by (1,002)

Items 901–1,000 of 1,002

1. JIB‑04 induces cell apoptosis via activation of the p53/Bcl‑2/caspase pathway in MHCC97H and HepG2 cells
   Weiguo Liao, Jie Liu, Bin Liu, Xiaojie Huang, Yongxin Yin, De Cai, Mingyi Li, Runzhi Zhu · 2018 · Oncology Reports
2. Harnessing the vulnerabilities of p53 mutants in lung cancer – Focusing on the proteasome: a new trick for an old foe?
   Eziafa Oduah, Steven R. Grossman · 2020 · Cancer Biology & Therapy
3. A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer
   Eunice Lee, Noor A. Lokman, Martin Klaus Oehler, Carmela Ricciardelli, Frank Grützner · 2020 · Cancers
4. The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families
   Caitlin T. Fierheller, Wejdan M. Alenezi, Patricia N. Tonin · 2021 · Cancers
5. Non-Invasive Saliva-based Detection of Gene Mutations in Oral Cancer Patients by Oral Rub and Rinse Technique
   Audrey Madonna D’Cruz, Dechamma Pandyanda Nanjappa, Marina Saldanha, Sahana Maben, Pushparaja Shetty, Anirban Chakraborty · 2021 · Asian Pacific Journal of Cancer Prevention
6. Subclonal landscape of cancer drives resistance to immune therapy.
   D. J. Craig, Morgan Bailey, Olivia Noe, Kada K Williams, L. Stanbery, D. Hamouda, J. Nemunaitis · 2022 · Cancer Treatment and Research Communications
7. Stratification From Heterogeneity of the Cell-Death Signal Enables Prognosis Prediction and Immune Microenvironment Characterization in Esophageal Squamous Cell Carcinoma
   Yiyuan Zhang, Yanxing Chen · 2022 · Frontiers in Cell and Developmental Biology
8. Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer
   Luiza Steffens Reinhardt, Kira Groen, Brianna C. Morten, Jean‐Christophe Bourdon, Kelly A. Avery‐Kiejda · 2022 · International Journal of Molecular Sciences
9. Association of LDLR, TP53 and MMP9 Gene Polymorphisms With Atherosclerosis in a Malaysian Study Population
   Zalinah Ahmad, Joan Anak Blin, Lekhraj Rampal Gyanchand Rampal, Rohayu Shahar Adnan, Norhafizah Mohtarrudin, Dayang Sarah Yasmine Abang Yusuf · 2023 · Current Problems in Cardiology
10. Association of TP53 gene polymorphisms with susceptibility of bladder cancer in Bangladeshi population
    Md. Bayejid Hosen, Md. Abdus Salam, Md. Fakhrul Islam, Ashfaque Hossain, Md. Zakir Hossain Howlader, Yearul Kabir · 2015 · Tumor Biology
11. Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation
    Zunamys Itzell Carrero, Madhu Kollareddy, Krishna M. Chauhan, Gopalakrishnan Ramakrishnan, Luis A. Martinez · 2016 · Oncotarget
12. Dynamical states, possibilities and propagation of stress signal
    Md. Zubbair Malik, Shahnawaz Ali, Soibam Shyamchand Singh, Romana Ishrat, R. K. Brojen Singh · 2017 · Scientific Reports
13. Identification of Local Clusters of Mutation Hotspots in Cancer-Related Genes and Their Biological Relevance
    Je‐Keun Rhee, Jinseon Yoo, Kyu Ryung Kim, Jeeyoon Kim, Yong‐Jae Lee, Byoung Chul Cho, Tae‐Min Kim · 2018 · IEEE Transactions on Computational Biology and Bioinformatics
14. Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles
    S. Antoun, David M. Atallah, Roula Tahtouh, Nada Alaaeddine, Malak Moubarak, Abir Khaddage, Eliane Nasr Ayoub, G. Chahine, George Hilal · 2018 · Cancer Cell International
15. Explaining cancer type specific mutations with transcriptomic and epigenomic features in normal tissues
    Khong-Loon Tiong, Chen‐Hsiang Yeang · 2018 · Scientific Reports
16. Involvement of ERK1/2-mediated ELK1/CHOP/DR5 pathway in 6-(methylsulfinyl)hexyl isothiocyanate-induced apoptosis of colorectal cancer cells
    Satoshi Yano, Shusong Wu, Kozue Sakao, De‐Xing Hou · 2019 · Bioscience Biotechnology and Biochemistry
17. Induced pluripotent stem cells of patients with Tetralogy of Fallot reveal transcriptional alterations in cardiomyocyte differentiation
    Marcel Grunert, Sandra Appelt, Sophia Schoenhals, Kerstin Mika, Huanhuan Cui, Ashley Cooper, Lukas Cyganek, Kaomei Guan, Silke Sperling · 2020 · Scientific Reports
18. Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors
    Ziad Omran, Mahmood Hassan Dalhat, Omeima Abdullah, Mohammed Kaleem, Salman Bakr I. Hosawi, Fahad Ahmed Al-Abbasi, Wei Wu, Hani Choudhry, Mahmoud Alhosin · 2021 · Cancers
19. Sputum-Based Molecular Biomarkers for the Early Detection of Lung Cancer: Limitations and Promise
    Connie E. Kim, Kam-Meng Tchou-Wong, William N. Rom · 2011 · Cancers
20. Unraveling the hidden complexity of cancer through long-read sequencing
    Qiuhui Li, Ayşe Gökçe Keşküş, Justin Wagner, Michal Izydorczyk, Winston Timp, Fritz Joachim Sedlazeck, Alison P. Klein, Justin M. Zook, Mikhail Kolmogorov, Michael C. Schatz · 2025 · Genome Research
21. Emerging biomarkers in bladder cancer: Translating molecular advances into precision oncology
    Matteo Ferro, Felice Crocetto, Letizia Maria Ippolita Jannello, Roberto Contieri, Ugo Giovanni Falagario, Alessandro Veccia, Michele Marchioni, Octavian Sabin Tătaru, Biagio Barone, Giuseppe Fallara et al. · 2025 · Critical Reviews in Oncology/Hematology
22. Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells
    Robert J. Rabelo-Fernández, Ginette S. Santiago-Sánchez, Rohit Kumar Sharma, Abiel Roche-Lima, Kelvin Carrasquillo, Ricardo A. Noriega Rivera, Blanca I. Quiñones‐Díaz, Swetha Rajasekaran, Jalal Siddiqui, Wayne O. Miles et al. · 2022 · International Journal of Molecular Sciences
23. A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer
    Jessica J. Miller, Kalvin Kwan, Christian Gaiddon, Tim Storr · 2022 · JBIC Journal of Biological Inorganic Chemistry
24. DNA- and RNA-Binding Proteins Linked Transcriptional Control and Alternative Splicing Together in a Two-Layer Regulatory Network System of Chronic Myeloid Leukemia
    Chuhui Wang, Xueqing Zong, Fanjie Wu, Ricky Wai Tak Leung, Yaohua Hu, Jing Qin · 2022 · Frontiers in Molecular Biosciences
25. Role of genetic testing in hepatic, pancreatic, and biliary cancers
    Daniel Brock Hewitt, Hassan Aziz, Zachary J. Brown, Timothy Michael Pawlik · 2022 · Surgical Oncology
26. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway
    Derek A. Franklin, Shijie Liu, Aiwen Jin, Pengfei Cui, Zengli Guo, Kyle C. Arend, Nathaniel J. Moorman, Shenghui He, Gang Greg Wang, Yisong Y. Wan et al. · 2022 · Journal of Biological Chemistry
27. An exploration of gastric cancer with heterogeneous mismatch repair status
    Xinyu Wang, Kang Jiang, Yajie Hu, Xinya Zhao, Lisha Yin, Xinting Diao, Xiuli Ma, Yu Xu, Yuezong Bai, Yan Zhang et al. · 2023 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
28. RETRACTED: Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53
    Bin Song, Jiajian Wang, Yixin Ren, Yong-Nan Su, Xueye Geng, Fan Yang, Hao Wang, Jihong Zhang · 2023 · Biomedicine & Pharmacotherapy · Retracted
29. Metal-Based Anticancer Complexes and p53: How Much Do We Know?
    Samah Mutasim Alfadul, Egor M. Matnurov, Alexander E. Varakutin, Maria V. Babak · 2023 · Cancers
30. Predicting Disease-Associated N7–Methylguanosine (m7G) Sites via Random Walk on Heterogeneous Network
    Huang Yi-ran, Zhihong Wu, Wei Lan, Cheng Zhong · 2023 · IEEE Transactions on Computational Biology and Bioinformatics
31. Genomic alterations and diagnosis of renal cancer
    Xingming Zhang, Hella Anna Bolck, Niels J. Rupp, Holger Moch · 2023 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
32. Targeting misfolding and aggregation of the amyloid-β peptide and mutant p53 protein using multifunctional molecules
    Lauryn Grcic, Grace Leech, Kalvin Kwan, Tim Storr · 2024 · Chemical Communications
33. Molecular precision medicine: Multi-omics-based stratification model for acute myeloid leukemia
    Teng Wang, Siyuan Cui, Chunyi Lyu, Zhenzhen Wang, Zonghong Li, Han Chen, Weilin Liu, Yan Wang, Ruirong Xu · 2024 · Heliyon
34. An overview of new biomolecular pathways in pathogen-related cancers
    Maria Lina Tornesello, Luigi Buonaguro, Franco M. Buonaguro · 2015 · Future Oncology
35. GFI1 Is Repressed by p53 and Inhibits DNA Damage-Induced Apoptosis
    Pei Du, Fangqiang Tang, Yaling Qiu, Fan Dong · 2013 · PLoS ONE
36. Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer
    Juan Martín Arriaga, I. Alda Bravo, L. Bruno, Sergio Morales Bayo, Adrián Hannois, Fernando Sánchez Loria, F. Pairola, Eduardo Huertas, María P. Roberti, Yamila Rocca et al. · 2012 · Human Pathology
37. Modified Proofreading PCR for Detection of Point Mutations, Insertions and Deletions Using a ddNTP-Blocked Primer
    Weiming Hao, Lujuan Fan, Qianqian Chen, Xiaoxiang Chen, Sichao Zhang, Ke Lan, Jian Lü, Chiyu Zhang · 2015 · PLoS ONE
38. TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts
    Jill E. Kucab, Edwin Zwart, Harry VAN STEEG, Mirjam Luijten, Heinz H. Schmeiser, David H. Phillips, Volker Manfred Arlt · 2015 · DNA repair
39. Genetics and epigenetics of myelodysplastic syndromes and response to drug therapy: new insights
    Saeid Shahrabi, Abbas Khosravi, Mohammad Shahjahani, Fakher Rahim, Najmaldin Saki · 2016 · Oncology Reviews
40. Multiscale mutation clustering algorithm identifies pan-cancer mutational clusters associated with pathway-level changes in gene expression
    William Poole, Kalle Leinonen, Ilya Shmulevich C, Theo Knijnenburg, Brady M. Bernard · 2017 · PLoS Computational Biology
41. Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy
    Maha S. Al-Keilani, Dua H. Alsmadi, Ruba S. Darweesh, Karem Hasan Alzoubi · 2018 · Clinical Pharmacology Advances and Applications
42. Case Report: Exome sequencing reveals recurrent RETSAT mutations and a loss-of-function POLDIP2 mutation in a rare undifferentiated tongue sarcoma
    Jason Y. K. Chan, Peony Hiu Yan Poon, Yong Zhang, Cherrie W. K. Ng, Wen Ying Piao, Meng Ma, Kevin Yuk-Lap Yip, Amy B. W. Chan, Vivian Wai Yan Lui · 2018 · F1000Research
43. A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells
    Ramasamy Paulmurugan, Rayhaneh Afjei, Thillai V. Sekar, Husam A. Babikir, Tarik F. Massoud · 2018 · Oncotarget
44. Cancer, Retrogenes, and Evolution
    Klaudia Staszak, Izabela Makałowska · 2021 · Life
45. Mutational analysis of p53 gene in cervical cancer and useful polymorphic variants in exons 3 and 4
    Michael Adedapo Gbadegesin, Olabode Ebenezer Omotoso, Timothy Oluwasola, Clement A. Okolo, Opeyemi S. Soremekun, Gabriel Olabiyi Ogun, Abideen Olayiwola Oluwasola, Oyeronke A. Odunola · 2021 · Egyptian Journal of Medical Human Genetics
46. Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer
    Xiaolin Zhang, Zhen Dong, Hongjuan Cui · 2021 · Biomolecules
47. Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer
    Nishat Manzar, Promit Ganguly, Umar Khalid Khan, Bushra Ateeq · 2023 · Seminars in Cancer Biology
48. Critical Analysis of Strand-Biased Somatic Mutation Signatures in TP53versusIg Genes, in Genome-Wide Data and the Etiology of Cancer
    Robyn Alice Lindley, Edward J. Steele · 2013 · ISRN Genomics
49. Application of bifurcation theory and siRNA-based control signal to restore the proper response of cancer cells to DNA damage
    Emilia Kozłowska, Krzysztof Puszyński · 2016 · Journal of Theoretical Biology
50. LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer
    Li-Xiang Ma, H. Saiyin · 2017 · PLoS ONE
51. Revealing protein networks and gene-drug connectivity in cancer from direct information
    Xianli Jiang, Emmanuel Martínez-Ledesma, Faruck Morcos · 2017 · Scientific Reports
52. Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics
    Jonathan L. Messerschmidt, Prianka Bhattacharya, Gerald L. Messerschmidt · 2017 · Current Oncology Reports
53. DNA sequencing of cytopathologically inconclusive EUS-FNA from solid pancreatic lesions suspicious for malignancy confirms EUS diagnosis
    Julie Isabelle Plougmann Gislinge, Pia Helene Klausen, Anders Toxværd, Armita Armina Abedi, Bojan Kovacevic, JohnGásdal Karstensen, Tim Svenstrup Poulsen, Evangelos Kalaitzakis, Estrid Vilma Solyom Høgdall, Peter Vilmann · 2019 · Endoscopic Ultrasound
54. An expert overview of emerging therapies for acute myeloid leukemia: novel small molecules targeting apoptosis, p53, transcriptional regulation and metabolism
    Kapil Saxena, Marina Y Konopleva · 2020 · Expert Opinion on Investigational Drugs
55. Functional germline variants in driver genes of breast cancer
    Stella Göhler, Miguel Inácio da Silva Filho, Robert Johansson, Kerstin Enquist, Roger Henriksson, Kari Hemminki, Per Lenner, Asta Försti · 2017 · Cancer Causes & Control
56. AI and ML for Development of Cell and Gene Therapy for Personalized Treatment
    Susmit Mhatre, Somanshi Shukla, Vivek P. Chavda, Lakshmikanth Gandikota, Vandana Bharat Patravale · 2023 · Wiley eBooks
57. Cytogenetics and Cytogenomics in Clinical Diagnostics: Genome Architecture, Structural Variants, and Translational Applications
    Concetta Federico, Desiree Brancato, Francesca Bruno, Elvira Coniglio, Valentina Sturiale, Salvatore Saccone · 2025 · Genes
58. G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of Chemotherapy and Immunotherapy in Bladder Cancer
    Lianhui Duan, Xuefei Liu, Ziwei Luo, Chen Zhang, Chun Jing Wu, Weiping Mu, Zhixiang Zuo, Xiao‐Qing Pei, Tian Shao · 2022 · Genes
59. Whole-Exome Sequencing Reveals Clinical Potential of Circulating Tumor DNA from Peritoneal Fluid and Plasma in Endometrial Cancer
    Hye-Yeon Ju, Sung Min Yoon, Jun Kyu Kang, Soo Young Hur, Se-Jin Kim, Youn Jin Choi, Mi-Ryung Han · 2022 · Cancers
60. Drug screening and biomarker gene investigation in cancer therapy through the human transcriptional regulatory network
    Zihao He, Kai Gao, Lei Dong, Liu Liu, Xinchi Qu, Zhengkai Zou, Yang Wu, Dechao Bu, Jincheng Guo, Yi Chen Zhao · 2023 · Computational and Structural Biotechnology Journal
61. Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancer
    Aiguang Wang, Cuiping Han, Hui Zhao, Zhaomin Zheng, Xin Ye, Rong Shan · 2023 · Journal of Cancer Research and Therapeutics
62. Myt1 overexpression mediates resistance to cell cycle and DNA damage checkpoint kinase inhibitors
    Sargun Sokhi, Cody Wayne Lewis, Amirali B. Bukhari, Joanne Hadfield, Edric J. Xiao, Jeremy Fung, Yea Jin Yoon, Wen‐Hsin Hsu, Armin M. Gamper, Gordon K. T. Chan · 2023 · Frontiers in Cell and Developmental Biology
63. A deep learning model predicts the presence of diverse cancer types using circulating tumor cells
    Somayah Albaradei, Nofe Ateq Alganmi, Abdulrahman Albaradie, Eaman Alharbi, Olaa Motwalli, Maha A. Thafar, Takashi Gojobori, Magbubah Essack, Xin Gao · 2023 · Scientific Reports
64. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting
    Stephan J. Reshkin, Rosa Angela Cardone, Tomas Koltai · 2024 · Cells
65. A hypoxia–glycolysis–lactate-related gene signature for prognosis prediction in hepatocellular carcinoma
    Xiaodan Qin, Huiling Sun, Shangshang Hu, Yuqin Pan, Shukui Wang · 2024 · BMC Medical Genomics
66. RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification
    Sun Mi Lee, Hyunjoo Oh · 2024 · Scientific Reports
67. Global insights into keloid formation: An international systematic review of regional genetic risk factors and commonalities
    Andrew J. James, Ricardo A. Torres‐Guzman, Sara C. Chaker, Matthew Sigel, Galen Perdikis, Dorothy M. Supp, Elizabeth L Slater · 2024 · Wound Repair and Regeneration
68. SLC7A9 suppression increases chemosensitivity by inducing ferroptosis via the inhibition of cystine transport in gastric cancer
    Haoran Feng, Junxian Yu, Zhuoqing Xu, Qingqing Sang, Fangyuan Li, Mengdi Chen, Yunqin Chen, Beiqin Yu, Nan Zhu, Jiazeng Xia et al. · 2024 · EBioMedicine
69. Enhancer regulatory networks globally connect non-coding breast cancer loci to cancer genes
    Yihan Wang, Daniel A. Armendariz, Lei Wang, Huan Zhao, Shiqi Xie, Gary C. Hon · 2025 · Genome biology
70. Twin target self-amplification-based DNA machine for highly sensitive detection of cancer-related gene
    Huo Ying Xu, Yifan Jiang, Dengyou Liu, Kai Liu, Yafeng Zhang, Suhong Yu, Zhifa Shen, Zai‐Sheng Wu · 2018 · Analytica Chimica Acta
71. Blood transcriptome analysis reveals gene expression features of breast-feeding rhesus macaque (Macaca mulatta) infants
    Yue Lan, 四川大学生命科学学院生物资源与生态环境教育部重点实验室，四川 成都610065,中国, Jiao Wang, Qiao Li Yang, Ruixiang Tang, Min Zhou, Guang-Lun Lei, Jing Li, Liang Zhang, Bisong Yue et al. · 2020 · 动物学研究
72. MDM2 as a target for ellagic acid‑mediated suppression of prostate cancer cells in vitro
    Yasir I. Mohammed Saleem, Mustafa I. Selim · 2020 · Oncology Reports
73. Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome
    Ofelia Cruz, Victoria Caloretti, Héctor Salvador, Verónica Celis, Vicente Santa‐María, Andrés Morales La Madrid, Mariona Suñol, Patricia Puerta, Jordi Muchart, Lucas Krauel et al. · 2021 · Hereditary Cancer in Clinical Practice
74. Oncolytic HSV: Underpinnings of Tumor Susceptibility
    Chase Kangas, Eric Krawczyk, Bin He · 2021 · Viruses
75. SNAI2-Mediated Repression of BIM Protects Rhabdomyosarcoma from Ionizing Radiation
    Long Wang, Nicole Rae Hensch, Kathryn M. Bondra, Prethish Sreenivas, Xiang R. Zhao, Jiangfei Chen, Rodrigo Moreno Campos, Kunal Baxi, Angelina V. Vaseva, Benjamin D. Sunkel et al. · 2021 · Cancer Research
76. Antiproliferative pharmacophore azo-hydrazone analogue BT-1F exerts death signalling pathway targeting STAT3 in solid tumour
    Banumathi, Ankith Sherapura, Vikas H. Malojirao, Zabiulla Zabiulla, B. S. Sharath, Prabhu Thirusangu, Riaz Mahmood, Suchetha Kumari, Shrinath M. Baliga, Shaukath Ara Khanum et al. · 2022 · Pharmacological Reports
77. Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer
    Xiaodong Song, Sheng Xin, Yucong Zhang, Jiaquan Mao, Chen Duan, Kai Cui, Liang Chen, Fan Li, Zheng Liu, Tao Wang et al. · 2022 · Frontiers in Cell and Developmental Biology
78. Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review
    Meijia Yu, Qin Zhang, Xia Zhao · 2022 · Frontiers in Oncology
79. Evolving therapeutic proteins to precisely kill cancer cells
    Rahela Zaman, Rowshan Ara Islam, Ezharul Hoque Chowdhury · 2022 · Journal of Controlled Release
80. Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer
    Xiaobo Wu, Xingbo Long, Chenkai Ma, Yin Celeste Cheuk, Mengbo Hu, Jimeng Hu, Haowen Jiang · 2022 · International Journal of Molecular Sciences
81. Bilateral Wilms Tumor with TP53 -Related Anaplasia
    Sergey D. Popov, Gordan M. Vujanic, Neil James Sebire, Tasnim Chagtai, Richard Dafydd Williams, Sucheta J. Vaidya, Kathy Pritchard‐Jones · 2013 · Pediatric and Developmental Pathology
82. Creation and preliminary characterization of a Tp53 knockout rat
    Aaron McCoy, Cynthia L Besch-Williford, Craig L. Franklin, Edward J. Weinstein, Xiaoxia Cui · 2012 · Disease Models & Mechanisms
83. Rational Manual and Automated Scoring Thresholds for the Immunohistochemical Detection of TP53 Missense Mutations in Human Breast Carcinomas
    Nicholas J. Taylor, Nana Nikolaishvili‐Feinberg, Bentley R. Midkiff, Kathleen Conway, Robert C. Millikan, Joseph Geradts · 2015 · Applied immunohistochemistry & molecular morphology
84. Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex
    Giovanna Carrà, Sabrina Crivellaro, Riccardo Taulli, Angelo Guerrasio, Giuseppe Nicola Saglio, Alessandro Morotti · 2016 · International Journal of Molecular Sciences
85. Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology
    Evgenii Shumilov, Johanna Flach, Thomas Pabst, Martin Fiedler, Anne Angelillo‐Scherrer, Lorenz H. P. Trümper, Raphael Joncourt, Alexander Kohlmann, Ulrike Bacher · 2018 · Critical Reviews in Oncology/Hematology
86. Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant Subline
    Tomoko Takimoto‐Shimomura, Hisao Nagoshi, Saori Maegawa, Yuto Fujibayashi, Taku Tsukamoto, Yayoi Matsumura‐Kimoto, Yoshimi Mizuno, Yoshiaki Chinen, Shinsuke Mizutani, Yuji Shimura et al. · 2018 · Cancer Genomics & Proteomics
87. RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas
    Pilar López‐Nieva, Pablo Fernández‐Navarro, Concepción Vaquero‐Lorenzo, María Villa‐Morales, Osvaldo Graña‐Castro, María Cobos-Fernández, José Luis López Lorenzo, Pilar Llamas, Laura González-Sánchez, Isabel Sastre et al. · 2018 · BMC Cancer
88. G1 phase cell cycle arrest in NSCLC in response to LZ-106, an analog of enoxacin, is orchestrated through ROS overproduction in a P53-dependent manner
    Lin Yang, Jieying Zhou, Fei Meng, Chengyu Fu, Xiaoqian Zou, Jinfeng Liu, Chengwan Zhang, Ren Xiang Tan, Zhiyu Li, Qinglong Guo et al. · 2018 · Carcinogenesis
89. Das HPV-getriebene Oropharynxkarzinom – Inzidenz, Trends, Diagnose und Therapie
    Steffen Wagner, Henrike Reder, Shachi Jenny Sharma, Nora Würdemann, Claus Wittekindt, Jens Peter Klußmann · 2018 · Der Urologe
90. Proteomic Analysis Reveals that Odoroside A Triggers G2/M Arrest and Apoptosis in Colorectal Carcinoma Through ROS‐p53 Pathway
    Yanyan Chen, Shiyuan Wen, Chun‐Miao Deng, Xingfeng Yin, Zhenghua Sun, Miaomiao Jiang, Qing‐Yu He · 2019 · PROTEOMICS
91. The Landscape of the Anti-Kinase Activity of the IDH1 Inhibitors
    Katarzyna Malarz, Jacek Mularski, Marcin Pacholczyk, Robert Musioł · 2020 · Cancers
92. An Efficient and Easy-to-Use Network-Based Integrative Method of Multi-Omics Data for Cancer Genes Discovery
    Ting Wei, Botao Fa, Chengwen Luo, Luke J. Johnston, Yue Zhang, Zhangsheng Yu · 2021 · Frontiers in Genetics
93. MicroRNA-324-5p–CUEDC2 Axis Mediates Gain-of-Function Mutant p53-Driven Cancer Stemness
    Dishari Ghatak, Arindam Datta, Tanaya Roychowdhury, Samit Chattopadhyay, Susanta Roychoudhury · 2021 · Molecular Cancer Research
94. Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non‐small cell lung cancer
    Jin Duan, Guoli Lv, Nanye Zhu, Xin Chen, Yang Washington Shao, Yong Liu, Zhao Wei, Yunfei Shi · 2022 · Thoracic Cancer
95. IARC TP53 Database
    Magali Olivier · 2015 · Springer eBooks
96. Phase Separation and Prion‐Like Aggregation of p53 Family Tumor Suppressors: From Protein Evolution to Cancer Treatment
    Jerson Lima Silva, Guilherme Caldas de Andrade, Elaine C. Petronilho, Gileno dos S. de Sousa, Michelle F. Mota, Julia Quarti, Francisca Hildemagna Guedes-da-Silva, Giulia D. S. Ferretti, Luciana Pereira Rangel, Tuane C. R. G. Vieira et al. · 2025 · Journal of Neurochemistry
97. Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer
    Wensheng Zhang, Yan Dong, Oliver A. Sartor, Kun Zhang · 2022 · Cancer Informatics
98. Translation of Cellular Senescence to Novel Therapeutics: Insights From Alternative Tools and Models
    Nurcan Inci, Dilanur Kamali, Erdogan Oguzhan Akyildiz, Eda Tahir Turanlı, Perinur Bozaykut · 2022 · Frontiers in Aging
99. Effect of miR-34a on the expression of clock and clock-controlled genes in DLD1 and Lovo human cancer cells with different backgrounds with respect to p53 functionality and 17β-estradiol-mediated regulation
    Roman Moravčík, Soňa Olejárová, Jana Zlacká, Iveta Herichová · 2023 · PLoS ONE
100. Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysis
     Moazzam Shahzad, Qamar Iqbal, Ezza Fatima Tariq, Mohammad Ammad-Ud-Din, Atif Butt, Ali Hassan Mushtaq, Fatima Ali, Sibgha Gull Chaudhary, Iqra Anwar, Jesus D. Gonzalez‐Lugo et al. · 2024 · Critical Reviews in Oncology/Hematology